A case report of Sandhoff disease
- PMID: 21153386
- PMCID: PMC3145082
- DOI: 10.1007/s00062-010-0035-4
A case report of Sandhoff disease
Abstract
Sandhoff disease is a rare and severe lysosomal storage disorder representing 7% of GM2 gangliosidoses. Bilateral thalamic involvement has been suggested as a diagnostic marker of Sandhoff disease. A case of an 18-month-old infant admitted for psychomotor regression and drug resistant myoclonic epilepsy is presented. Cerebral CT scan showed bilateral and symmetrical thalamic hyperdensity. MRI revealed that the thalamus was hyperintense on T(1)-weighted images and hypointense on T2-weighted images with a hypersignal T2 of the white matter. Enzymatic assays objectified a deficiency of both hexosaminidases A and B confirming the diagnosis of Sandhoff disease.
Similar articles
-
Thalamic hyperdensity--is it a diagnostic marker for Sandhoff disease?Brain Dev. 1993 Sep-Oct;15(5):387-8. doi: 10.1016/0387-7604(93)90128-u. Brain Dev. 1993. PMID: 8279657
-
[Clinical and molecular characteristics of a child with juvenile Sandhoff disease].Zhonghua Er Ke Za Zhi. 2014 Apr;52(4):313-6. Zhonghua Er Ke Za Zhi. 2014. PMID: 24915922 Chinese.
-
Neuroimaging findings of four patients with Sandhoff disease.Pediatr Neurol. 1999 Aug;21(2):562-5. doi: 10.1016/s0887-8994(99)00041-7. Pediatr Neurol. 1999. PMID: 10465144
-
[Adult form of GM2-gangliosidosis: a man and 2 sisters with hexosaminidase-A and -B deficiency (Sandhoff disease) and literature review].Schweiz Med Wochenschr. 1996 May 4;126(18):757-64. Schweiz Med Wochenschr. 1996. PMID: 8693300 Review. German.
-
Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts.Mol Neurobiol. 2014 Aug;50(1):159-67. doi: 10.1007/s12035-013-8605-5. Epub 2013 Dec 20. Mol Neurobiol. 2014. PMID: 24356898 Review.
Cited by
-
Microglial replacement in a Sandhoff disease mouse model reveals myeloid-derived β-hexosaminidase is necessary for neuronal health.Nat Commun. 2025 Aug 27;16(1):7994. doi: 10.1038/s41467-025-63237-0. Nat Commun. 2025. PMID: 40866328 Free PMC article.
-
Clinical and Molecular Characteristics of Two Chinese Children with Infantile Sandhoff Disease and Review of the Literature.J Mol Neurosci. 2020 Apr;70(4):481-487. doi: 10.1007/s12031-019-01409-6. Epub 2020 Jan 9. J Mol Neurosci. 2020. PMID: 31919734 Review.
-
Decrease in Myelin-Associated Lipids Precedes Neuronal Loss and Glial Activation in the CNS of the Sandhoff Mouse as Determined by Metabolomics.Metabolites. 2020 Dec 30;11(1):18. doi: 10.3390/metabo11010018. Metabolites. 2020. PMID: 33396723 Free PMC article.
-
TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology.Neurobiol Dis. 2016 Jan;85:174-186. doi: 10.1016/j.nbd.2015.11.001. Epub 2015 Nov 3. Neurobiol Dis. 2016. PMID: 26545928 Free PMC article.
-
Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease.J Lipid Res. 2017 Jul;58(7):1306-1314. doi: 10.1194/jlr.M073395. Epub 2017 Apr 4. J Lipid Res. 2017. PMID: 28377426 Free PMC article.
References
-
- Gutierrez-Solana LG, Ruiz-Falco ML, Garcia-Penas JJ. Evolutive neuroradiological alterations in Sandhoff’s disease. Rev Neurol. 1996;24:1263–6. - PubMed
-
- Van der Knaap MS, Valk J, editors. Magnetic resonance of myelin, myelination, and myelin disorders. Berlin: Springer; 1995.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical